• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Global kinetic mechanism describing single nucleotide incorporation for RNA polymerase I reveals fast UMP incorporation.描述 RNA 聚合酶 I 单个核苷酸掺入的全局动力学机制揭示了 UMP 的快速掺入。
Biophys Chem. 2024 Sep;312:107281. doi: 10.1016/j.bpc.2024.107281. Epub 2024 Jun 8.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
High-resolution Sequencing Reveals that the Paf1 Complex May be a Conserved Transcription Elongation Factor for Eukaryotic RNA Polymerase I.高分辨率测序表明,Paf1复合物可能是真核生物RNA聚合酶I保守的转录延伸因子。
J Mol Biol. 2025 Sep 1;437(17):169220. doi: 10.1016/j.jmb.2025.169220. Epub 2025 May 19.
4
Nicotine receptor partial agonists for smoking cessation.尼古丁受体部分激动剂用于戒烟。
Cochrane Database Syst Rev. 2023 May 5;5(5):CD006103. doi: 10.1002/14651858.CD006103.pub8.
5
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
6
Pathogen-reduced platelets for the prevention of bleeding.用于预防出血的去病原体血小板。
Cochrane Database Syst Rev. 2013 Mar 28(3):CD009072. doi: 10.1002/14651858.CD009072.pub2.
7
Brexanolone, zuranolone and related neurosteroid GABA receptor positive allosteric modulators for postnatal depression.用于产后抑郁症的布雷沙诺龙、祖拉诺龙及相关神经甾体GABA受体正变构调节剂。
Cochrane Database Syst Rev. 2025 Jun 26;6(6):CD014624. doi: 10.1002/14651858.CD014624.pub2.
8
Uterine artery embolization for symptomatic uterine fibroids.子宫动脉栓塞术治疗有症状的子宫肌瘤。
Cochrane Database Syst Rev. 2014 Dec 26;2014(12):CD005073. doi: 10.1002/14651858.CD005073.pub4.
9
123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.用于诊断神经母细胞瘤的123I-间碘苄胍闪烁扫描术和18F-氟代脱氧葡萄糖正电子发射断层显像
Cochrane Database Syst Rev. 2015 Sep 29;2015(9):CD009263. doi: 10.1002/14651858.CD009263.pub2.
10
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.

引用本文的文献

1
NTPs compete in the active site of RNA polymerases I and II.NTPs 在 RNA 聚合酶 I 和 II 的活性部位竞争。
Biophys Chem. 2024 Nov;314:107302. doi: 10.1016/j.bpc.2024.107302. Epub 2024 Aug 3.

本文引用的文献

1
The A12.2 Subunit Plays an Integral Role in Pyrophosphate Release of RNA Polymerase I.A12.2 亚基在 RNA 聚合酶 I 的焦磷酸释放中发挥重要作用。
J Mol Biol. 2023 Aug 1;435(15):168186. doi: 10.1016/j.jmb.2023.168186. Epub 2023 Jun 22.
2
Protocol for monitoring and analyzing single nucleotide incorporation by S. cerevisiae RNA polymerases.酿酒酵母RNA聚合酶监测和分析单核苷酸掺入的实验方案。
STAR Protoc. 2023 Mar 24;4(2):102191. doi: 10.1016/j.xpro.2023.102191.
3
Transient-State Kinetic Analysis of the RNA Polymerase II Nucleotide Incorporation Mechanism.RNA 聚合酶 II 核苷酸掺入机制的瞬态动力学分析。
Biochemistry. 2023 Jan 3;62(1):95-108. doi: 10.1021/acs.biochem.2c00608. Epub 2022 Dec 16.
4
RNA Polymerase I Is Uniquely Vulnerable to the Small-Molecule Inhibitor BMH-21.RNA聚合酶I对小分子抑制剂BMH-21异常敏感。
Cancers (Basel). 2022 Nov 11;14(22):5544. doi: 10.3390/cancers14225544.
5
Uncovering the mechanisms of transcription elongation by eukaryotic RNA polymerases I, II, and III.揭示真核生物RNA聚合酶I、II和III的转录延伸机制。
iScience. 2022 Oct 8;25(11):105306. doi: 10.1016/j.isci.2022.105306. eCollection 2022 Nov 18.
6
Multi-start Evolutionary Nonlinear OpTimizeR (MENOTR): A hybrid parameter optimization toolbox.多启动进化非线性优化器(MENOTR):一种混合参数优化工具箱。
Biophys Chem. 2021 Dec;279:106682. doi: 10.1016/j.bpc.2021.106682. Epub 2021 Sep 29.
7
Transient-state kinetic analysis of multi-nucleotide addition catalyzed by RNA polymerase I.RNA聚合酶I催化的多核苷酸添加的瞬态动力学分析
Biophys J. 2021 Oct 19;120(20):4378-4390. doi: 10.1016/j.bpj.2021.09.008. Epub 2021 Sep 10.
8
The N-terminal domain of the A12.2 subunit stimulates RNA polymerase I transcription elongation.A12.2亚基的N端结构域刺激RNA聚合酶I转录延伸。
Biophys J. 2021 May 18;120(10):1883-1893. doi: 10.1016/j.bpj.2021.03.007. Epub 2021 Mar 16.
9
Defining the divergent enzymatic properties of RNA polymerases I and II.定义 RNA 聚合酶 I 和 II 的酶学性质差异。
J Biol Chem. 2021 Jan-Jun;296:100051. doi: 10.1074/jbc.RA120.015904. Epub 2020 Nov 24.
10
Targeting the RNA Polymerase I Transcription for Cancer Therapy Comes of Age.靶向 RNA 聚合酶 I 转录用于癌症治疗已日趋成熟。
Cells. 2020 Jan 21;9(2):266. doi: 10.3390/cells9020266.

描述 RNA 聚合酶 I 单个核苷酸掺入的全局动力学机制揭示了 UMP 的快速掺入。

Global kinetic mechanism describing single nucleotide incorporation for RNA polymerase I reveals fast UMP incorporation.

机构信息

Department of Chemistry, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, AL 35294, USA.

出版信息

Biophys Chem. 2024 Sep;312:107281. doi: 10.1016/j.bpc.2024.107281. Epub 2024 Jun 8.

DOI:10.1016/j.bpc.2024.107281
PMID:38889653
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11260521/
Abstract

RNA polymerase I (Pol I) is responsible for synthesizing ribosomal RNA, which is the rate limiting step in ribosome biogenesis. We have reported wide variability in the magnitude of the rate constants defining the rate limiting step in sequential nucleotide additions catalyzed by Pol I. in this study we sought to determine if base identity impacts the rate limiting step of nucleotide addition catalyzed by Pol I. To this end, we report a transient state kinetic interrogation of AMP, CMP, GMP, and UMP incorporations catalyzed by Pol I. We found that Pol I uses one kinetic mechanism to incorporate all nucleotides. However, we found that UMP incorporation is faster than AMP, CMP, and GMP additions. Further, we found that endonucleolytic removal of a dimer from the 3' end was fastest when the 3' terminal base is a UMP. It has been previously shown that both downstream and upstream template sequence identity impacts the kinetics of nucleotide addition. The results reported here show that the incoming base identity also impacts the magnitude of the observed rate limiting step.

摘要

RNA 聚合酶 I(Pol I)负责合成核糖体 RNA,这是核糖体生物发生中的限速步骤。我们已经报道了 Pol I 催化的连续核苷酸添加过程中限速步骤的速率常数的幅度存在广泛的可变性。在这项研究中,我们试图确定碱基身份是否会影响 Pol I 催化的核苷酸添加的限速步骤。为此,我们报告了对 Pol I 催化的 AMP、CMP、GMP 和 UMP 掺入的瞬态动力学研究。我们发现 Pol I 使用一种动力学机制来掺入所有核苷酸。然而,我们发现 UMP 的掺入速度比 AMP、CMP 和 GMP 的添加速度快。此外,我们发现当 3'末端碱基是 UMP 时,从 3'端内切切除二聚体最快。先前已经表明,下游和上游模板序列的身份都会影响核苷酸添加的动力学。这里报道的结果表明,进入碱基的身份也会影响观察到的限速步骤的幅度。